[go: up one dir, main page]

WO2019046661A1 - Pharmaceutical composition containing various forms & strains of cannabis - Google Patents

Pharmaceutical composition containing various forms & strains of cannabis Download PDF

Info

Publication number
WO2019046661A1
WO2019046661A1 PCT/US2018/048982 US2018048982W WO2019046661A1 WO 2019046661 A1 WO2019046661 A1 WO 2019046661A1 US 2018048982 W US2018048982 W US 2018048982W WO 2019046661 A1 WO2019046661 A1 WO 2019046661A1
Authority
WO
WIPO (PCT)
Prior art keywords
cannabis
kief
strain
mash compound
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2018/048982
Other languages
French (fr)
Inventor
Charles Jefferson MILLER
Danen KIRK CHRISTOPHER THIBODEAU
Bill James PLIFKA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Edivape International LLC
Original Assignee
Edivape International LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edivape International LLC filed Critical Edivape International LLC
Publication of WO2019046661A1 publication Critical patent/WO2019046661A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/348Cannabaceae
    • A61K36/3482Cannabis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Definitions

  • the present invention relates to edible and smokable forms of cannabis and more particularly a process for combing multiple forms and strains of cannabis into a single composition that may be smoked and/or digested by eating, thereby allowing a user to receive the benefit of multiple strains of cannabis from a single dose.
  • Cannabis has long been used for medicinal purposes and recreational purposes.
  • Cannabis strains may be either pure or hybrid varieties of the Cannabis genus of plants, which include the species C. sativa and C. indica.
  • strains While both strains share the same cannabinoids, they vary in levels of THC, CBD, and Terpenes that classify them as Sativa or Indica.
  • Sativa' s cannabinoid profile is dominated by high THC levels and low or no CBD levels.
  • Indica's chemical profile shows a more balanced mix, with moderate THC levels and higher levels of CBD.
  • Indica strains relax muscles and work as general analgesics, also helping with sleep. A cancer patient hoping to relieve the pain from chemotherapy may benefit from the effects of an Indica plant.
  • Sativa strains produce more of a euphoric high, lifting the consumer's mood and therapeutically relieving stress, indicating Sativas may be useful at relieving anxiety and depression.
  • Varieties are developed to intensity specific characteristics of the plant, or to differentiate the strain for the purposes of marketing or to make it more effective as a drug.
  • Established strains offer many qualities that very from one strain to the next. Many of these qualities would be beneficial to users if a process was available wherein the strains were able to be combined in a consistent manner.
  • the primary object of the present invention is to provide a process wherein a plurality of cannabis strains may be combined in a consistent manner.
  • the present invention is a pharmaceutical composition of ground cannabis flour, cannabis oil and cannabis kief wherein a process forming the composition allows for a variety of blends to be created into a single end product.
  • the strain or strains of cannabis used to form the composition may be taken from a plurality of cannabis strains, thus making a compound of flowers which is finely ground and separated from cannabis kief.
  • cannabis oil is warmed to a low temperature until the cannabis oil is thin enough to stir.
  • the ground cannabis flour and cannabis oil are blended into an even consistency, thereby creating a mash compound.
  • the mash compound is then warmed in a humid oven until an even saturation is achieved.
  • the mash compound is cooled to room temperature.
  • the mash compound may then be separated into desired sizes and weights. After the mash compound is separated into desired doses, it may be molded into shapes. The outer surface of the molded mash compound is then covered with cannabis kief.
  • the present invention is a pharmaceutical composition of cannabis flour, cannabis oil and cannabis kief wherein a process forming the composition allows for a variety of blends to be created into a single end product.
  • the strains of cannabis used to form the composition may be taken from a plurality of cannabis strains, thus making a compound of flowers which is finely ground and separated from cannabis kief.
  • cannabis oil is warmed to a low temperature until the cannabis oil is thin enough to stir.
  • the ground cannabis flour and cannabis oil are blended into an even consistency, thereby creating a mash compound.
  • the mash compound is then warmed in a humid oven until an even saturation is achieved. Then the mash compound is cooled to room temperature.
  • the mash compound may then be separated into desired sizes and weights. After the mash compound is separated into desired doses, it may be molded into shapes. The outer surface of the molded mash compound is then covered with kief.
  • the resulting composition comprises the mash compound having formed as described above using at least one flour produced from a first strain of cannabis mixed with at least one oil produced from a second strain of cannabis.
  • the resulting mash compound is a formable compound that is then separated into individual doses and each dose is formed into a geometric shape, such as a ball, cube and so forth, or other equivalent shapes.
  • the formed shapes are then coated in at least one layer of cannabis kief dust produced from a third strain of cannabis.
  • the following examples illustrate various resulting embodiments of the composition of the present invention being made using the process of the present invention to combine various strains of cannabis.
  • the cannabis oil used to form the mash compound of the present invention and the resulting composition is preferably derived from a different strain of cannabis from which the cannabis flour and the cannabis kief are derived from.
  • Said cannabis kief may be substituted by a cannabis shatter, cannabis crystalline or equivalent cannabis product that will form an outer coating on the formed mash compound.
  • the ingredients are chosen from a Cannabis Strain A, Cannabis Strain B and Cannabis Strain C, each of which has one or more unique properties different from that of the other strains being used:
  • Cannabis Flour Cannabis Strain A
  • Cannabis Oil Cannabis Strain B
  • Cannabis Kief Cannabis Strain C EXAMPLE 2
  • Cannabis Flour Cannabis Strain B
  • Cannabis Oil Cannabis Strain A
  • Cannabis Kief Cannabis Strain C
  • Cannabis Flour Cannabis Strain C
  • Cannabis Oil Cannabis Strain A
  • Cannabis Kief Cannabis Strain B
  • Cannabis Flour Cannabis Strain C
  • Cannabis Oil Cannabis Strain B
  • Cannabis Kief Cannabis Strain A
  • the process of the present invention allows a consistent rotation of alternating strains of cannabis which are all combined into a single composition wherein accurate dosing may be achieved.
  • the cannabis oil, cannabis flour and the cannabis kief may all be derived from the same strain of cannabis and formed into the unique structure of the present invention using the process of the present invention as follows: EXAMPLE 5
  • Cannabis Flour Cannabis Strain A
  • Cannabis Oil Cannabis Strain A
  • Cannabis Kief Cannabis Strain A

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A process wherein a plurality of cannabis strains may be combined into a single dose of cannabis. The resulting composition is an accurately dosed combination of various strains of cannabis and the desired benefits of each of those strains. The resulting composition may be formed into various shapes, thereby making the composition easy to administer orally or through smoking or vaping.

Description

PHARMACEUTICAL COMPOSITION CONTAINING VARIOUS FORMS
& STRAINS OF CANNABIS
FIELD OF THE INVENTION
The present invention relates to edible and smokable forms of cannabis and more particularly a process for combing multiple forms and strains of cannabis into a single composition that may be smoked and/or digested by eating, thereby allowing a user to receive the benefit of multiple strains of cannabis from a single dose.
BACKGROUND OF THE INVENTION
Cannabis has long been used for medicinal purposes and recreational purposes. Cannabis strains may be either pure or hybrid varieties of the Cannabis genus of plants, which include the species C. sativa and C. indica.
While both strains share the same cannabinoids, they vary in levels of THC, CBD, and Terpenes that classify them as Sativa or Indica. Sativa' s cannabinoid profile is dominated by high THC levels and low or no CBD levels. Indica's chemical profile shows a more balanced mix, with moderate THC levels and higher levels of CBD. Indica strains relax muscles and work as general analgesics, also helping with sleep. A cancer patient hoping to relieve the pain from chemotherapy may benefit from the effects of an Indica plant. Sativa strains produce more of a euphoric high, lifting the consumer's mood and therapeutically relieving stress, indicating Sativas may be useful at relieving anxiety and depression.
Varieties are developed to intensity specific characteristics of the plant, or to differentiate the strain for the purposes of marketing or to make it more effective as a drug. Established strains offer many qualities that very from one strain to the next. Many of these qualities would be beneficial to users if a process was available wherein the strains were able to be combined in a consistent manner.
SUMMARY OF THE INVENTION
The primary object of the present invention is to provide a process wherein a plurality of cannabis strains may be combined in a consistent manner.
The present invention is a pharmaceutical composition of ground cannabis flour, cannabis oil and cannabis kief wherein a process forming the composition allows for a variety of blends to be created into a single end product. To form the composition, first the strain or strains of cannabis used to form the composition may be taken from a plurality of cannabis strains, thus making a compound of flowers which is finely ground and separated from cannabis kief. Then, cannabis oil is warmed to a low temperature until the cannabis oil is thin enough to stir. Next, the ground cannabis flour and cannabis oil are blended into an even consistency, thereby creating a mash compound. The mash compound is then warmed in a humid oven until an even saturation is achieved. Then the mash compound is cooled to room temperature. The mash compound may then be separated into desired sizes and weights. After the mash compound is separated into desired doses, it may be molded into shapes. The outer surface of the molded mash compound is then covered with cannabis kief.
The above and other objects, features and advantages of the present invention should become even more readily apparent to those skilled in the art upon a reading of the following detailed description in conjunction with the drawings wherein there is shown and described illustrative embodiments of the invention.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
The present invention is a pharmaceutical composition of cannabis flour, cannabis oil and cannabis kief wherein a process forming the composition allows for a variety of blends to be created into a single end product. To form the composition, first the strains of cannabis used to form the composition may be taken from a plurality of cannabis strains, thus making a compound of flowers which is finely ground and separated from cannabis kief. Then, cannabis oil is warmed to a low temperature until the cannabis oil is thin enough to stir. Next, the ground cannabis flour and cannabis oil are blended into an even consistency, thereby creating a mash compound. The mash compound is then warmed in a humid oven until an even saturation is achieved. Then the mash compound is cooled to room temperature. The mash compound may then be separated into desired sizes and weights. After the mash compound is separated into desired doses, it may be molded into shapes. The outer surface of the molded mash compound is then covered with kief. The resulting composition comprises the mash compound having formed as described above using at least one flour produced from a first strain of cannabis mixed with at least one oil produced from a second strain of cannabis. The resulting mash compound is a formable compound that is then separated into individual doses and each dose is formed into a geometric shape, such as a ball, cube and so forth, or other equivalent shapes. The formed shapes are then coated in at least one layer of cannabis kief dust produced from a third strain of cannabis.
The following examples illustrate various resulting embodiments of the composition of the present invention being made using the process of the present invention to combine various strains of cannabis. The cannabis oil used to form the mash compound of the present invention and the resulting composition is preferably derived from a different strain of cannabis from which the cannabis flour and the cannabis kief are derived from. Said cannabis kief may be substituted by a cannabis shatter, cannabis crystalline or equivalent cannabis product that will form an outer coating on the formed mash compound. As illustrated below, the ingredients are chosen from a Cannabis Strain A, Cannabis Strain B and Cannabis Strain C, each of which has one or more unique properties different from that of the other strains being used:
EXAMPLE 1
Cannabis Flour: Cannabis Strain A
Cannabis Oil: Cannabis Strain B
Cannabis Kief: Cannabis Strain C EXAMPLE 2
Cannabis Flour: Cannabis Strain B
Cannabis Oil: Cannabis Strain A
Cannabis Kief: Cannabis Strain C
EXAMPLE 3
Cannabis Flour: Cannabis Strain C
Cannabis Oil: Cannabis Strain A
Cannabis Kief: Cannabis Strain B
EXAMPLE 4
Cannabis Flour: Cannabis Strain C
Cannabis Oil: Cannabis Strain B
Cannabis Kief: Cannabis Strain A
As illustrated above, the process of the present invention allows a consistent rotation of alternating strains of cannabis which are all combined into a single composition wherein accurate dosing may be achieved. Alternatively, the cannabis oil, cannabis flour and the cannabis kief may all be derived from the same strain of cannabis and formed into the unique structure of the present invention using the process of the present invention as follows: EXAMPLE 5
Cannabis Flour: Cannabis Strain A
Cannabis Oil: Cannabis Strain A
Cannabis Kief: Cannabis Strain A
It is to be understood that while a preferred embodiment of the invention is illustrated, it is not to be limited to the specific form or arrangement of parts herein described and shown. It will be apparent to those skilled in the art that various changes may be made without departing from the scope of the invention and the invention is not to be considered limited to what is shown and described in the specification and drawings.

Claims

CLAIMS Having thus described my invention, I claim:
1. A process for forming a pharmaceutical composition comprising the steps of: producing a ground cannabis flour from a first strain of cannabis;
producing a cannabis oil from a second strain of cannabis;
producing a cannabis kief from a third strain of cannabis;
mixing said ground cannabis flour with said cannabis oil to produce a mash compound; and
coating said mash compound with an outer layer of said cannabis kief.
2. The process of claim 1 further comprising the step of:
separating the said mash compound into a plurality of smaller doses.
3. The process of claim 1 further comprising the step of:
forming said mash compound into a geometric shape.
4. The process of claim 2 further comprising the step of:
forming said separated doses into geometric shapes.
5. The process of claim 1 further comprising the step of:
warming said cannabis oil prior to mixing said cannabis flour into said cannabis oil to form said mash compound.
6. The process of claim 1 further comprising the step of:
warming said mash compound in a humid oven to achieve an even saturation throughout the mash compound.
7. The process of claim 5 further comprising the step of:
warming said mash compound in a humid oven to achieve an even saturation throughout the mash compound.
8. The process of claim 1 wherein:
said cannabis kief is substituted for a cannabis shatter.
9. The process of claim 1 wherein:
said cannabis kief is substituted for a cannabis crystalline.
10. A process for forming a pharmaceutical composition comprising the steps of: producing a ground cannabis flour from a first strain of cannabis;
producing a cannabis oil from a second strain of cannabis;
producing a cannabis kief from a third strain of cannabis;
mixing said ground cannabis flour with said cannabis oil to produce a mash compound;
coating said mash compound with an outer layer of said cannabis kief; separating the said mash compound into a plurality of smaller doses; and forming said separated doses into geometric shapes.
11. The process of claim 10 further comprising the step of:
warming said cannabis oil prior to mixing said cannabis flour into said cannabis oil to form said mash compound.
12. The process of claim 10 further comprising the step of:
warming said mash compound in a humid oven to achieve an even saturation throughout the mash compound.
13. The process of claim 11 further comprising the step of:
warming said mash compound in a humid oven to achieve an even saturation throughout the mash compound.
14. The process of claim 10 wherein:
said cannabis kief is substituted for a cannabis shatter.
15. The process of claim 10 wherein:
said cannabis kief is substituted for a cannabis crystalline.
16. A pharmaceutical composition comprising:
a ground cannabis flour from a first strain of cannabis;
a cannabis oil from a second strain of cannabis;
a cannabis kief from a third strain of cannabis;
said ground cannabis flour mixed with said cannabis oil to produce a mash compound; and
said mash compound coated with an outer layer of said cannabis kief.
17. The pharmaceutical composition of claim 16 wherein:
said mash compound is formed into at least one geometric shape.
18. The pharmaceutical composition of claim 16 wherein:
said cannabis kief is substituted for a cannabis shatter.
19. The pharmaceutical composition of claim 16 wherein:
said cannabis kief is substituted for a cannabis crystaline.
PCT/US2018/048982 2017-09-01 2018-08-30 Pharmaceutical composition containing various forms & strains of cannabis Ceased WO2019046661A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201715694220A 2017-09-01 2017-09-01
US15/694,220 2017-09-01

Publications (1)

Publication Number Publication Date
WO2019046661A1 true WO2019046661A1 (en) 2019-03-07

Family

ID=65526104

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2018/048982 Ceased WO2019046661A1 (en) 2017-09-01 2018-08-30 Pharmaceutical composition containing various forms & strains of cannabis

Country Status (1)

Country Link
WO (1) WO2019046661A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016084075A1 (en) * 2014-11-26 2016-06-02 One World Cannabis Ltd Synergistic use of cannabis for treating multiple myeloma
US20170226077A1 (en) * 2016-02-09 2017-08-10 Robin James Bach Production of 11-Hydroxy-THC

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016084075A1 (en) * 2014-11-26 2016-06-02 One World Cannabis Ltd Synergistic use of cannabis for treating multiple myeloma
US20170226077A1 (en) * 2016-02-09 2017-08-10 Robin James Bach Production of 11-Hydroxy-THC

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"What is kief and how can you use it?", LEAFLY, 15 October 2014 (2014-10-15), Retrieved from the Internet <URL:www.leafly.com/news/cannabis-101/what-is-kief> *
RABER J. C. ET AL.: "Understanding dabs: contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing", THE JOURNAL OF TOXICOLOGICAL SCIENCES, 2015, pages 797 - 803, XP055579838 *

Similar Documents

Publication Publication Date Title
CN104206483A (en) Moon cake made of edible wild herbs and processing process of moon cake
CN102144676B (en) Cool edible oil and preparation method thereof
Puvača et al. Spices and herbs in broilers nutrition: hot red pepper (Capsicum annuum L.) and its mode of action
CN107712619B (en) A kind of barley green juice flour noodles and preparation method thereof
CN109673763A (en) A kind of chilli oil and its preparation process
WO2019046661A1 (en) Pharmaceutical composition containing various forms &amp; strains of cannabis
KR101331064B1 (en) Wheat flour goods including estern prickly pear and producting method for the goods
KR20130072097A (en) A manufacturing method of chicken powder with mountain ginseng extract
CN106418386A (en) Soft capsule capable of protecting gastric mucosa, and preparation method thereof
CN102370135A (en) Tomato and beef nutritious noodle
KR20170078220A (en) Fuctionality bread incluing butterbur powder and how to make it
CN109156697A (en) A kind of clearing-oil chafing dish bottom flavorings and preparation method thereof
CN104509774B (en) A kind of sweet wormwood cake and preparation method
CN102894287A (en) Rose scent noodle
KR102217801B1 (en) Composition for improving bone health and female menopausal symptoms, including Cirsium japonicum var. maackii (Maxim.) Matsum extract and Thymus vulgaris extract
Hu et al. Eating" rubbish"? Exploring the herbal secrets of" Laji-He," a traditional herbal rice snack from southern China
KR101542202B1 (en) Attractive pill using Maackia amurensis Rupr. et Maxim and making method of it
KR20170055098A (en) Frozen rice bread dough and method of producing rice steamed bread using the same
CN104366406B (en) A kind of seasoning powder material composition for smoked fish
KR101671366B1 (en) Method for producing ramie leaves chopped noodles and ramie leaves chopped noodles produced by the same method
Al‐Marazeeq et al. Effects of aqueous cactus (Opuntia ficus-indica (L.) Mill.) cladodes extract on wheat dough and pan bread quality characteristics
Chavan et al. International Journal of Pharmaceutical Development & Technology
CN108925729A (en) A kind of small introduction chocolate and preparation method thereof
CN104543691A (en) Blood-enriching flour
CN105661322A (en) Rice crust containing grape seed component

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18849929

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18849929

Country of ref document: EP

Kind code of ref document: A1